Medical Countermeasures Monoclonal Antibody Shows Broad SARS-CoV-2 Neutralization in Preclinical StudyGlobal Biodefense StaffJuly 8, 2025
Medical Countermeasures New Multi-Epitope Mpox Vaccine Shows Strong Potential in SilicoGlobal Biodefense StaffJuly 8, 2025
Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine Contracts + Grants November 15, 2018 …
Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets Featured News November 11, 2018 …
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated Featured News November 8, 2018 …
Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’ Antimicrobial Resistance November 6, 2018 …
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine Medical Countermeasures August 12, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018 …
